Author(s):
Sushila D. Chavan, Nayana V. Pimpodkar, Amruta S. Kadam, Puja S.Gaikwad
Email(s):
sushiladchavan@gmail.com
DOI:
10.5958/2231-5659.2016.00007.2 
Address:
Sushila D. Chavan1*, Nayana V. Pimpodkar2, Amruta S. Kadam1, Puja S.Gaikwad1
1Lecturer, College of Pharmacy (D. Pharm) Degaon, Satara (MH) India- 415 004.
2Principal, College of Pharmacy (D. Pharm) Degaon, Satara (MH) India- 415 004.
*Corresponding Author
Published In:
Volume - 6,
Issue - 1,
Year - 2016
ABSTRACT:
Quality by design (QbD) is an essential part of the modern advance to pharmaceutical quality. QbD is best key to build a quality in all pharmaceutical products. Under this concepts of Be throughout design and growth of product, it is important to identify desire product performance report [Target product profile (TPP), Quality Target product profile (QTPP)] and identify critical quality attributes (CQA). To recognize the impact of raw material [critical material attributes (CAM)], critical process parameters (CPP) on the CQAs and identification and control sources of changeability. The plan of pharmaceutical development is to design a quality products and its manufacturing process always deliver the future performance of the product. The base of Quality by design is ICH Guidelines Q8 for Pharmaceutical for development, Q9 quality risk management, Q10 for pharmaceutical quality systems.
Cite this article:
Sushila D. Chavan, Nayana V. Pimpodkar, Amruta S. Kadam, Puja S.Gaikwad. Quality by Design. Asian J. Res. Pharm. Sci. 6(1): Jan.-Mar., 2016; Page 45-50. doi: 10.5958/2231-5659.2016.00007.2
Cite(Electronic):
Sushila D. Chavan, Nayana V. Pimpodkar, Amruta S. Kadam, Puja S.Gaikwad. Quality by Design. Asian J. Res. Pharm. Sci. 6(1): Jan.-Mar., 2016; Page 45-50. doi: 10.5958/2231-5659.2016.00007.2 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2016-6-1-7